Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies.
Dams
E T
ET
van der Meer
J W
JW
D000293:Adolescent; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D003365:Costs and Cost Analysis; D005260:Female; D006699:Home Care Services; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D016756:Immunoglobulins, Intravenous / Q000191:economics / Q000627:therapeutic use; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D007279:Injections, Subcutaneous / Q000009:adverse effects; D008297:Male; D008875:Middle Aged
D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous